Market Cap
$8.0M
SURG
SurgePays, Inc.
$0.1500 ▲ +0.00%
Prev close $0.1500Market cap$8.0M
ConsensusStrong Buy
12-mo target$3.75 (+2458.0%)
▲ Bullish
Analyst conviction 9/10
High Impact Filing (7/10)3 Institutional Exits Media & Telecom
Snapshot
The big-picture read on SURG right now — valuation, ownership and activity at a glance.
Cap Size
Nano Cap
Analyst Consensus
Strong Buy (86%)
Inst. Holders
23 funds
Inst. Value
$487.8K
Inst. Activity
1 buys / 3 sells
Insider Activity
$21.2K buy / $0.00 sell
Insider Net $
$21.2K
Social Sentiment
64° Warm
SEC Reports
7
Press Releases
2
Price chart 30d -9.1%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 30, 2026 short_volume
Sep 3, 2026 SEC Short Volume: SURG — 56.8% short (1.8M / 3.1M)
Short: 1,757,905 | Exempt: 1,065 | TRF Vol: 3,096,261 | Short Ratio: 56.8% | Off-exchange volume (da
SurgePays formed LWP-SURGE, LLC, a Wyoming LLC intended to serve as the vehicle for a proposed joint venture with All Pr
8-K — Impact 2/10
SurgePays reported Q2 2026 GAAP net income of $1.29M ($0.05 EPS), a sharp reversal from a $7.08M loss in Q2 2025, driven
PRESS-RELEASE — Impact 6/10
Jul 31, 2026 Insider
Weisberg Laurie was granted 315,179 shares
Director
Jul 31, 2026 Insider
KEYS DAVID N was granted 315,179 shares
Director
Jul 31, 2026 Insider
Jul 29, 2026 SEC May David Allen was granted 315,179 shares
Director
SurgePays filed an 8-K to address 'incorrect information' circulating online regarding its subsidiary Torch Wireless and
8-K — Impact 4/10
SurgePays reported strong month-over-month acceleration in its rent-to-own pilot with Low Weekly Payments, reaching $142
Impact 5/10
Analyst ratings buy % +14.7%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
86% rate it Buy or better · 7 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Sep 14, 2026 | Ascendiant Capital | MAINTAIN | Buy | 40% |
| Jun 10, 2026 | Ascendiant Capital | MAINTAIN | Buy | 40% |
| Apr 17, 2026 | Ascendiant Capital | MAINTAIN | Buy | 40% |
| Dec 22, 2025 | Ascendiant Capital | MAINTAIN | Buy | 40% |
| Oct 3, 2025 | Ascendiant Capital | MAINTAIN | Buy | 40% |
| Jun 16, 2025 | Ascendiant Capital | MAINTAIN | Buy | 40% |
| Apr 22, 2025 | Ascendiant Capital | MAINTAIN | Buy | 40% |
| Dec 16, 2024 | Ascendiant Capital | MAINTAIN | Buy | 40% |
| Jun 6, 2024 | Ascendiant Capital | MAINTAIN | Buy | 40% |
| Apr 1, 2024 | Ascendiant Capital | MAINTAIN | Buy | 40% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Aug 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Jul 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Jun 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| May 1, 2026 | 2 | 4 | 2 | 0 | 0 | 75% | |
| Apr 1, 2026 | 2 | 4 | 2 | 0 | 0 | 75% | |
| Mar 1, 2026 | 2 | 4 | 2 | 0 | 0 | 75% | |
| Feb 1, 2026 | 2 | 4 | 2 | 0 | 0 | 75% |
Price targets
Where 1 covering analysts think SURG trades over the next 12 months.
$3.75 +2458.0% upside Strong Buy
Current$0.1466 Low$3.75 Median$3.75 High$3.75 1 analysts
$3.75$3.75
Analyst rating None as of Oct 3, 2026
Social media sentiment mood +20.0%
Retail-investor mood aggregated across social media. 0° = very bearish, 100° = very bullish.
64°
Warm
BearishNeutralBullish
Recent posts
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
7 SEC filing reports analyzed · 0 bullish, 4 bearish, 1 mixed, 2 neutral · avg impact 6.1/10.Plus 2 press releases.
NEUTRAL8-K2/10
SurgePays formed LWP-SURGE, LLC, a Wyoming LLC intended to serve as the vehicle for a proposed joint
Sep 3, 2026
MIXEDPRESS-RELEASE6/10
SurgePays reported Q2 2026 GAAP net income of $1.29M ($0.05 EPS), a sharp reversal from a $7.08M los
Aug 14, 2026
NEUTRAL8-K4/10
SurgePays filed an 8-K to address 'incorrect information' circulating online regarding its subsidiar
Jul 29, 2026
BEARISH8-K7/10
SurgePays reported Q1 2026 revenue of $16.0M (+51% YoY) but a net loss of $-12.1M (EPS -$0.51) that
May 20, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Sep 30, 2026
short_volume
Short Volume: SURG — 56.8% short (1.8M / 3.1M)
Short: 1,757,905 | Exempt: 1,065 | TRF Vol: 3,096,261 | Short Ratio: 56.8% | Off-exchange volume (dark pool + OTC)
Sep 29, 2026
short_volume
Short Volume: SURG — 67.5% short (4.0M / 5.9M)
Short: 4,006,241 | Exempt: 21,300 | TRF Vol: 5,932,175 | Short Ratio: 67.5% | Off-exchange volume (dark pool + OTC)
Sep 24, 2026
short_volume
Short Volume: SURG — 62.6% short (0.4M / 0.7M)
Short: 448,575 | Exempt: 0 | TRF Vol: 716,288 | Short Ratio: 62.6% | Off-exchange volume (dark pool + OTC)
Sep 22, 2026
short_volume
Short Volume: SURG — 55.6% short (1.7M / 3.1M)
Short: 1,722,614 | Exempt: 13,200 | TRF Vol: 3,098,038 | Short Ratio: 55.6% | Off-exchange volume (dark pool + OTC)
Sep 21, 2026
short_volume
Short Volume: SURG — 57.3% short (1.7M / 2.9M)
Short: 1,685,938 | Exempt: 1,983 | TRF Vol: 2,943,560 | Short Ratio: 57.3% | Off-exchange volume (dark pool + OTC)
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Next FY | $0.01 | $0.01–$0.01 | 102.3% | -80.0% | 0↑ 1↓ | $0.1B | 1 |
| Current Q | $-0.07 | $-0.07–$-0.07 | 81.6% | +12.5% | 1↑ 0↓ | $0.0B | 1 |
| Next Q | $-0.05 | $-0.05–$-0.05 | 92.8% | -150.0% | 1↑ 0↓ | $0.0B | 1 |
| Current FY | $-0.44 | $-0.44–$-0.44 | 75.6% | +37.1% | 0↑ 1↓ | $0.1B | 1 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $-0.070 | — |
| 7d ago | $-0.080 | +0.010 |
| 30d ago | $-0.080 | +0.010 |
| 60d ago | $-0.080 | +0.010 |
| 90d ago | $-0.080 | +0.010 |
Institutional ownership
Which big funds own SURG (from quarterly 13F filings) and who is adding or trimming.
23 institutional holders with $487.8K total value (1,351,612 shares) as of 2026-Q2. Top holders: VANGUARD, GEODE, VANGUARD. Net selling activity: 3 institutions trimmed/exited vs 1 added.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 567,358 | $204.8K | 42.0% | — |
| GEODE CAPITAL MANAGEMENT, LLC | 168,647 | $60.9K | 12.5% | ADD +35.7% |
| VANGUARD FIDUCIARY TRUST CO | 83,235 | $30.0K | 6.2% | — |
| CITADEL ADVISORS LLC | 83,163 | $30.0K | 6.2% | — |
| Cetera Investment Advisers | 66,000 | $23.8K | 4.9% | ADD +43.5% |
| STATE STREET CORP | 61,800 | $22.3K | 4.6% | ADD +72.6% |
| CITADEL ADVISORS LLC | 54,100 | $19.5K | 4.0% | — |
| NORTHERN TRUST CORP | 52,661 | $19.0K | 3.9% | ADD +94.0% |
| RENAISSANCE TECHNOLOGIES LLC | 50,900 | $18.4K | 3.8% | ADD +43.6% |
| JANE STREET GROUP, LLC | 44,128 | $15.9K | 3.3% | — |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | TRIM | 70,254 | 29,331 | -58.3% | $10.6K |
| UBS Group AG | TRIM | 74,802 | 24,551 | -67.2% | $8.9K |
| GROUP ONE TRADING LLC | DOUBLED | 393 | 13,572 | +3353.4% | $4.9K |
| SIMPLEX TRADING, LLC | TRIM | 109 | 29 | -73.4% | $10.00 |
| GEODE CAPITAL MANAGEMENT, LLC | ADD | 165,039 | 223,997 | +35.7% | $168.2K |
| UBS Group AG | DOUBLED | 22,722 | 74,802 | +229.2% | $56.2K |
| Cetera Investment Advisers | ADD | 46,000 | 66,000 | +43.5% | $49.6K |
| GROUP ONE TRADING LLC | TRIM | 1,212 | 393 | -67.6% | $295.00 |
| SIMPLEX TRADING, LLC | NEAR_EXIT | 812 | 109 | -86.6% | $81.00 |
| NORTHERN TRUST CORP | ADD | 27,151 | 52,661 | +94.0% | $87.9K |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
4 insiders, 10 transactions. Net $21.2K — $21.2K bought, $0.00 sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 31, 2026 | Weisberg Laurie | Director | AWARD | 315,179 | — | — |
| Jul 31, 2026 | KEYS DAVID N | Director | AWARD | 315,179 | — | — |
| Jul 31, 2026 | May David Allen | Director | AWARD | 315,179 | — | — |
| Jun 5, 2026 | May David Allen | Director | BUY | 34,716 | $0.5255 | $18.2K |
| Jun 4, 2026 | May David Allen | Director | BUY | 121 | $0.5255 | $63.59 |
| Jun 3, 2026 | May David Allen | Director | BUY | 5,413 | $0.5255 | $2.8K |
| Jun 1, 2026 | Cox Kevin Brian | CEO & Chairman | AWARD | 500,000 | — | — |
| Apr 1, 2026 | Cox Kevin Brian | CEO & Chairman | AWARD | 500,000 | — | — |
| Mar 24, 2026 | Cox Kevin Brian | CEO & Chairman | GIFT | 270,745 | — | — |
| Mar 23, 2026 | Cox Kevin Brian | CEO & Chairman | AWARD | 800,000 | $1.25 | $1.0M |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for SURG.
Shares short
5,114,724
Settlement Sep 15, 2026
Change vs prior
+1548.5%
Semi-monthly cycle
Days to cover
1.0
At avg daily volume
Of shares outstanding
≈9.7%
Estimate — not % of float
All SURG filing & press-release reports (9)
- 8-K reportSep 3, 2026
- PRESS-RELEASE reportAug 14, 2026
- 8-K reportJul 29, 2026
- PRESS-RELEASE reportJul 29, 2026
- PRESS-RELEASE reportJun 5, 2026
- 8-K reportMay 20, 2026
- PRESS-RELEASE reportMay 11, 2026
- 8-K reportApr 16, 2026
- PRESS-RELEASE reportApr 14, 2026